infectious-disease

Documents about infectious-disease

• Social contact patterns across levels of deprivation in England, and implications for infectious disease transmission#478512Europe PMC
• Arresting Vertical Transmission of Hepatitis B Virus#836386ClinicalTrials.gov
• A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects#847674ClinicalTrials.gov
• Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)#860981ClinicalTrials.gov
• LYMPH NODE INTEGRITY AND FUNCTION AS CRITICAL DETERMINANTS OF IMMUNE RECONSTITUTION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION#929141ScholarlyCommons
• IMPROVING CAR-T CELL PERFORMANCE WITH TARGETED DELIVERY OF CYTOKINES AND CYTOKINE SIGNALS#929225ScholarlyCommons
• EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19#1045339ClinicalTrials.gov
• Hepatitis C Viremia and the Risk of Chronic Kidney Disease in HIV-Infected Individuals#612227eScholarship
• Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019#335770OpenAlex
• Progress and challenges in development of minimum essential dataset for disease surveillance through a One Health lens: a scoping review#125738Europe PMC
• Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.#387247ClinicalTrials.gov
• The Patient-Reported Outcomes Project of HCV-TARGET#825127ClinicalTrials.gov
• Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease#885615ClinicalTrials.gov
• A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population#18720ClinicalTrials.gov
• Recent measles virus infection increased the severity of infectious disease in WWI with the exception of pandemic influenza#18864bioRxiv / medRxiv
• Forecastability of infectious disease time series: are some seasons and pathogens intrinsically more difficult to forecast?#125401NCBI PubMed Central
• Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study#231808IRIS
• Evaluating the benefits of Muntingia calabura L. (aratiles) on maternal and neonatal health#234213Animo Repository
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys#256954ClinicalTrials.gov
• Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)#268052ClinicalTrials.gov
• Editorial: Microbiota, antibiotic resistance, and host-microbe interactions: a comprehensive exploration of infectious disease dynamics.#360614NCBI PubMed Central
• Operating characteristics of analysis methods for clinical trials in viral respiratory disease: A simulation study protocol#407687bioRxiv / medRxiv
• Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source#872102ClinicalTrials.gov
• Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine#897913ClinicalTrials.gov
• A Counterfactual Framework for Estimating Infectious Disease Prevalence under Repeated Testing with Symptomatic and Contact-Tracing Components#987142arXiv (All)
• Ebola and Marburg Virus Vaccines#901254ClinicalTrials.gov
• Analysis of Lyme Disease Lesions#1030272ClinicalTrials.gov
• Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease#899580ClinicalTrials.gov
• Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature#67954bioRxiv / medRxiv
• Plasma proteomics identifies early markers of endothelial and inflammatory activation associated with dengue disease severity in children#67995bioRxiv / medRxiv
• Contribution de l’apicoplaste à la phase chronique de la toxoplasmose#137533HAL (France)
• Risk Stratification in Kidney Stone Disease: Environmental Drivers and Perioperative Infectious Outcomes#167663Harvard DASH
• Immune System Regulation: Inhibitory Checkpoint Receptors#169458ODU Digital Commons
• INfectious DIsease REgistry BIObank#174927ClinicalTrials.gov
• Occupational Risk Profiles for Infectious Disease Transmission in the Philippines: A Data-Driven Clustering Analysis#266316bioRxiv / medRxiv
• Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease : a community's view#278020SUNScholar
• Prevalence, Clonal Context, and Clinical Correlates of Arr in Klebsiella Pneumoniae from a Specialized Infectious Disease Hospital.#458600NCBI PubMed Central
• Developing an Evaluation Framework for Infectious Disease Modelling-to-Policy Pathways: A Qualitative Study Across Five Continents#475782Europe PMC
• Behavioral Immunity Suppresses an Epizootic in Caribbean Spiny Lobsters#645980ODU Digital Commons
• Online Learning Portal on Under Five Pneumonia#807969ClinicalTrials.gov
• Acceptability of Telehealth Triage Using Robotic Systems in COVID-19#839341ClinicalTrials.gov
• HOST-VIRUS HARMONY: ALTO AT THE INTERPLAY BETWEEN MERKEL CELL POLYOMAVIRUS AND HOST INNATE IMMUNITY#929250ScholarlyCommons
• Host Interferon-Mediated Bacterial Interference to Prevent MRSA#929261ScholarlyCommons
• The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis#967909ClinicalTrials.gov
• Incomplete immunization coverage and its related factors among children aged 1-5 years: evidence from the Indonesia Family Life Survey 5#314107African Journals Online
• Operational research in infectious disease outbreak response: An analysis of the World Health Organization’s Disease Outbreak News#338834PLOS
• The effect of natural climate variability on future vector-borne disease suitability: A mathematical modelling study#465478PLOS
• Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995#912452ClinicalTrials.gov
• Peptide-Based Strategies to Combat Infectious Diseases: From Arsenic-Containing RiPP as Antibiotics to Anti-Parasitic Inhibitors Targeting PMT#246117DigitalCommons@Kennesaw State University
• Gene Therapy for Chronic Granulomatous Disease#908159ClinicalTrials.gov